Pharmacological Similarities Between Native Brain and Heterologously Expressed Alpha4beta2 Nicotinic Receptors

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1999 Dec 1

PMID 10578144

Citations 10

Authors

N Shafaee

M Houng

A Truong

N Viseshakul

A Figl

S Sandhu

J R Forsayeth

L P Dwoskin

P A Crooks

B N Cohen

Affiliations

Soon will be listed here.

Abstract

1 We studied the pharmacological properties of native rat brain and heterologously expressed rat alpha4beta2 nicotinic receptors immunoprecipitated onto a fixed substrate with the anti-alpha4 antibody mAb 299. 2 Immunodepletion with the anti-beta2 antibody mAb 270 showed that 89% of the mAb-299-precipitated rat brain receptors contained beta2. 3 The association and dissociation rate constants for 30 pM +/-[3H]-epibatidine binding to alpha4beta2 receptors expressed in oocytes were 0.02+/-0.01 and 0.03+/-0.01 min-1 (+/-standard error, degrees of freedom=7 - 8) at 20 - 23 degrees C. 4 The Hill coefficients for +/-[3H]epibatidine binding to the native brain, alpha4beta2 receptors expressed in oocytes, and alpha4beta2 receptors expressed in CV-1 cells (using recombinant adenovirus) were 0.69 - 0.70 suggesting a heterogeneous receptor population. Fits of the +/-[3H]-epibatidine concentration-binding data to a two-site model gave KD s of 8 - 30 and 560 - 1,200 pM. The high-affinity sites comprised 73 - 74% of the native brain and oocyte alpha4beta2 receptor population, 85% of the CV-1 alpha4beta2 receptor population. 5 The expression of rat alpha4beta2 receptors in CV-1 cells using vaccinia viral infection-transfection resulted in a more homogeneous receptor population (Hill coefficient of 1. 0+/-0.2). Fits of the +/-[3H]-epibatidine binding data to a single-site model gave a KD of 40+/-3 pM. 6 DHbetaE (IC50=260-470 nM) and the novel nicotine analogue NDNI (IC50=7-10 microM) inhibited 30 pM+/-[3H]-epibatidine binding to the native brain and heterologously expressed alpha4beta2 receptors equally well. 7 The results show that alpha4beta2-containing nicotinic receptors in the rat brain and heterologously expressed rat alpha4beta2 receptors have similar affinities for +/-[3H]-epibatidine, DHbetaE, and NDNI.

Citing Articles

Stoichiometry of the Heteromeric Nicotinic Receptors of the Renshaw Cell.

Lamotte dIncamps B, Zorbaz T, Dingova D, Krejci E, Ascher P J Neurosci. 2018; 38(21):4943-4956.

PMID: 29724797 PMC: 6596121. DOI: 10.1523/JNEUROSCI.0070-18.2018.

Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation.

Govind A, Vallejo Y, Stolz J, Yan J, Swanson G, Green W Elife. 2017; 6.

PMID: 28718768 PMC: 5546804. DOI: 10.7554/eLife.25651.

Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.

Indurthi D, Pera E, Kim H, Chu C, McLeod M, McIntosh J Biochem Pharmacol. 2014; 89(1):131-40.

PMID: 24548457 PMC: 5089836. DOI: 10.1016/j.bcp.2014.02.002.

Characterizing low affinity epibatidine binding to α4β2 nicotinic acetylcholine receptors with ligand depletion and nonspecific binding.

Person A, Wells G BMC Biophys. 2011; 4:19.

PMID: 22112852 PMC: 3287110. DOI: 10.1186/2046-1682-4-19.

Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors.

Harpsoe K, Ahring P, Christensen J, Jensen M, Peters D, Balle T J Neurosci. 2011; 31(30):10759-66.

PMID: 21795528 PMC: 6623092. DOI: 10.1523/JNEUROSCI.1509-11.2011.

References

Jones N, Shenk T . Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell. 1979; 17(3):683-9. DOI: 10.1016/0092-8674(79)90275-7. View

Marubio L, Lena C, Le Novere N, de Kerchove dExaerde A, Huchet M, Damaj M . Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 1999; 398(6730):805-10. DOI: 10.1038/19756. View

Whiting P, Lindstrom J . Pharmacological properties of immuno-isolated neuronal nicotinic receptors. J Neurosci. 1986; 6(10):3061-9. PMC: 6568798. View

Marks M, Stitzel J, Romm E, Wehner J, Collins A . Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Mol Pharmacol. 1986; 30(5):427-36. View

Fuerst T, Niles E, Studier F, Moss B . Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A. 1986; 83(21):8122-6. PMC: 386879. DOI: 10.1073/pnas.83.21.8122. View

Whiting P, Lindstrom J . Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc Natl Acad Sci U S A. 1987; 84(2):595-9. PMC: 304257. DOI: 10.1073/pnas.84.2.595. View

Whiting P, Lindstrom J . Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J Neurosci. 1988; 8(9):3395-404. PMC: 6569436. View

Elroy-Stein O, Fuerst T, Moss B . Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc Natl Acad Sci U S A. 1989; 86(16):6126-30. PMC: 297788. DOI: 10.1073/pnas.86.16.6126. View

Duvoisin R, Deneris E, Patrick J, Heinemann S . The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: beta 4. Neuron. 1989; 3(4):487-96. DOI: 10.1016/0896-6273(89)90207-9. View

10.

Cooper E, Couturier S, BALLIVET M . Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature. 1991; 350(6315):235-8. DOI: 10.1038/350235a0. View

11.

Whiting P, Schoepfer R, Lindstrom J, Priestley T . Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol Pharmacol. 1991; 40(4):463-72. View

12.

Flores C, ROGERS S, Pabreza L, Wolfe B, Kellar K . A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol. 1992; 41(1):31-7. View

13.

Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992; 89(12):5547-51. PMC: 49329. DOI: 10.1073/pnas.89.12.5547. View

14.

Patrick J . Gene transcripts for the nicotinic acetylcholine receptor subunit, beta4, are distributed in multiple areas of the rat central nervous system. Brain Res Mol Brain Res. 1992; 16(3-4):339-44. DOI: 10.1016/0169-328x(92)90244-6. View

15.

Sargent P . The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci. 1993; 16:403-43. DOI: 10.1146/annurev.ne.16.030193.002155. View

16.

Hill Jr J, Zoli M, Bourgeois J, Changeux J . Immunocytochemical localization of a neuronal nicotinic receptor: the beta 2-subunit. J Neurosci. 1993; 13(4):1551-68. PMC: 6576729. View

17.

Peng X, Gerzanich V, Anand R, Whiting P, Lindstrom J . Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol. 1994; 46(3):523-30. View

18.

Covernton P, Kojima H, Sivilotti L, Gibb A, Colquhoun D . Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes. J Physiol. 1994; 481 ( Pt 1):27-34. PMC: 1155863. DOI: 10.1113/jphysiol.1994.sp020416. View

19.

Picciotto M, Zoli M, Lena C, BESSIS A, Lallemand Y, Le Novere N . Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature. 1995; 374(6517):65-7. DOI: 10.1038/374065a0. View

20.

Zoli M, Le Novere N, Hill Jr J, Changeux J . Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J Neurosci. 1995; 15(3 Pt 1):1912-39. PMC: 6578133. View